• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhancing Administrative Claims Data: Feasibility, Validation and Application of Linking Medicare Claims Data and National Marrow Donor Program Search Data.增强行政索赔数据:链接医疗保险索赔数据和国家骨髓捐献者计划搜索数据的可行性、验证和应用。
JCO Clin Cancer Inform. 2022 Oct;6:e2200069. doi: 10.1200/CCI.22.00069.
2
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.大剂量化疗及自体造血干细胞救援用于高危神经母细胞瘤患儿
Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD006301. doi: 10.1002/14651858.CD006301.pub4.
3
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
4
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.大剂量化疗及自体造血干细胞救援用于高危神经母细胞瘤患儿
Cochrane Database Syst Rev. 2013 Aug 22(8):CD006301. doi: 10.1002/14651858.CD006301.pub3.
5
Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.干细胞移植治疗急性白血病的临床效果和成本效益:系统评价。
Health Technol Assess. 2010 Dec;14(54):iii-iv, ix-xi, 1-141. doi: 10.3310/hta14540.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比,HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.

本文引用的文献

1
Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.癌症登记数据与 ASCO 的 CancerLinQ 电子健康记录数据的链接:优势、局限性和经验教训的评估。
JCO Clin Cancer Inform. 2022 Mar;6:e2100149. doi: 10.1200/CCI.21.00149.
2
An overview of real-world data sources for oncology and considerations for research.肿瘤学真实世界数据来源概述及研究考量
CA Cancer J Clin. 2022 May;72(3):287-300. doi: 10.3322/caac.21714. Epub 2021 Dec 29.
3
Barriers to Access to Hematopoietic Cell Transplantation among Patients with Acute Myeloid Leukemia in Virginia.弗吉尼亚州急性髓系白血病患者接受造血细胞移植的障碍。
Transplant Cell Ther. 2021 Oct;27(10):869.e1-869.e9. doi: 10.1016/j.jtct.2021.06.030. Epub 2021 Jul 2.
4
Probabilistic linkage without personal information successfully linked national clinical datasets.无需个人信息的概率链接成功链接了国家临床数据集。
J Clin Epidemiol. 2021 Aug;136:136-145. doi: 10.1016/j.jclinepi.2021.04.015. Epub 2021 Apr 28.
5
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.国家骨髓捐赠者计划-赞助的 HLA 错配无关供者骨髓移植使用移植后环磷酰胺的多中心 II 期试验。
J Clin Oncol. 2021 Jun 20;39(18):1971-1982. doi: 10.1200/JCO.20.03502. Epub 2021 Apr 27.
6
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.基于维奈克拉的疗法在异基因造血细胞移植后复发的急性髓系白血病中的挽救性应用。
Blood Cancer J. 2021 Mar 4;11(3):49. doi: 10.1038/s41408-021-00437-z.
7
Thirty-Day Re-observation, Chronic Re-observation, and Neighborhood Disadvantage.30 天再观察、慢性再观察和邻里劣势。
Mayo Clin Proc. 2020 Dec;95(12):2644-2654. doi: 10.1016/j.mayocp.2020.06.059.
8
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.社区贫困与儿科异基因造血细胞移植结局:CIBMTR 分析。
Blood. 2021 Jan 28;137(4):556-568. doi: 10.1182/blood.2020006252.
9
Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.在美国国家登记处搜索激活后进行异基因造血细胞移植的可能性:患者年龄、疾病和搜索预后的影响。
Transplant Cell Ther. 2021 Feb;27(2):184.e1-184.e13. doi: 10.1016/j.bbmt.2020.10.004. Epub 2020 Oct 10.
10
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.造血干细胞移植治疗成人初发急性髓系白血病:美国移植和细胞治疗学会的循证综述。
Transplant Cell Ther. 2021 Jan;27(1):6-20. doi: 10.1016/j.bbmt.2020.09.020. Epub 2020 Sep 20.

增强行政索赔数据:链接医疗保险索赔数据和国家骨髓捐献者计划搜索数据的可行性、验证和应用。

Enhancing Administrative Claims Data: Feasibility, Validation and Application of Linking Medicare Claims Data and National Marrow Donor Program Search Data.

机构信息

National Marrow Donor Program/Be The Match, Minneapolis, MN.

Center for International Blood and Marrow Transplant Research, Minneapolis, MN.

出版信息

JCO Clin Cancer Inform. 2022 Oct;6:e2200069. doi: 10.1200/CCI.22.00069.

DOI:10.1200/CCI.22.00069
PMID:36228178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9848571/
Abstract

PURPOSE

Administrative claims data provide real-world service utilization of acute myeloid leukemia (AML) treatment, but lacks insight into treatment delays or barriers. The National Marrow Donor Program (NMDP)/Be The Match Search (Search) data contains information on donor search, but lacks information on treatment received if allogeneic hematopoietic cell transplant (HCT) is not performed. We hypothesized that linking these two data sets would create a rich resource to define factors associated with receiving HCT that could not be evaluated with either data set alone.

METHODS

A subset of 2010-2016 Medicare administrative claims data was linked with Search data. A total of 5,351 patients with AML age 65-74 years (HCT = 607, no HCT = 4,744) were identified using Medicare. These patients were then linked to 93,800 records with a donor search between 2009 and 2016. Patient date of birth, sex, disease, ZIP code, transplant center/hospital, and diagnosis date were used for matching. Exploratory analysis was conducted to identify predictors associated with receiving HCT for patients with AML who received a search.

RESULTS

The data sets were successfully linked, showing high sensitivity and specificity. The final cohort included 5,085 patients with AML (HCT = 533, no HCT = 4,552). Of 97 patients who received HCT without a matched search, more than 85% received a related donor HCT. Of those not receiving HCT, 609 had a matched NMDP search and 3,943 did not have a matched NMDP search. Multivariate analysis showed time to search, age, diagnosis year, race/ethnicity, and neighborhood education status associated with receiving HCT.

CONCLUSION

Methods herein demonstrate the feasibility of linking Search and Medicare data. Similar methods may be applied to answer critical questions regarding barriers to HCT, thereby identifying areas to improve access to care.

摘要

目的

行政索赔数据提供了急性髓细胞白血病(AML)治疗的实际服务利用情况,但缺乏对治疗延迟或障碍的了解。国家骨髓捐献者计划(NMDP)/Be The Match Search(Search)数据包含有关供者搜索的信息,但如果未进行异基因造血细胞移植(HCT),则缺乏有关所接受治疗的信息。我们假设将这两个数据集链接起来将创建一个丰富的资源,以确定与接受 HCT 相关的因素,而这些因素无法仅通过任何一个数据集来评估。

方法

2010-2016 年医疗保险行政索赔数据的一个子集与 Search 数据相关联。使用医疗保险确定了年龄在 65-74 岁的 AML 患者共 5351 例(HCT=607 例,无 HCT=4744 例)。然后,将这些患者与 2009 年至 2016 年之间进行供者搜索的 93800 条记录相关联。患者的出生日期、性别、疾病、邮政编码、移植中心/医院和诊断日期用于匹配。进行了探索性分析,以确定与接受 AML 患者接受搜索相关的接受 HCT 的预测因素。

结果

数据集成功链接,显示出高灵敏度和特异性。最终队列包括 5085 例 AML 患者(HCT=533 例,无 HCT=4552 例)。在 97 例未进行匹配搜索但接受 HCT 的患者中,超过 85%的患者接受了相关供者 HCT。在未接受 HCT 的患者中,有 609 例进行了匹配的 NMDP 搜索,而有 3943 例未进行匹配的 NMDP 搜索。多变量分析显示,搜索时间、年龄、诊断年份、种族/民族和社区教育状况与接受 HCT 相关。

结论

本文中介绍的方法证明了将 Search 和医疗保险数据链接的可行性。类似的方法可以应用于回答有关 HCT 障碍的关键问题,从而确定改善获得护理的途径。